BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.3.1//EN
TZID:Europe/Helsinki
X-WR-TIMEZONE:Europe/Helsinki
BEGIN:VEVENT
UID:486@inflames.utu.fi
DTSTART;TZID=Europe/Helsinki:20260520T120000
DTEND;TZID=Europe/Helsinki:20260520T130000
DTSTAMP:20260518T130824Z
URL:https://inflames.utu.fi/events/inflames-guest-seminar-professor-antoni
 o-lanzavecchia/
SUMMARY:InFLAMES Guest Seminar: Professor Antonio Lanzavecchia
DESCRIPTION:\n\nInFLAMES Guest Seminar: Professor Antonio Lanzavecchia\n\nM
 ay 20 at 12:00\n\nin Medisiina C\, Osmo Järvi lecture hall\n\nProfessor A
 ntonio Lanzavecchia\, National Institute of Molecular Genetics (INGM)\, Mi
 lano\, Italy\nImmunodominance in CD8 T cell responses\n\nHost: Sirpa Jalka
 nen (sirjal@utu.fi)\n\nCoffee and sandwiches served at 11:30.\n\n(Those ou
 tside Turku\, please request the online link from sampo.koivunen@utu.fi by
  May 19.)\n\nProfessor Antonio Lanzavecchia is known for his work on antig
 en presentation\, T cell activation\, immunological memory and human monoc
 lonal antibodies. Lanzavecchia obtained a medical degree from the Universi
 ty of Pavia\, where he specialized in paediatrics and in infectious diseas
 es. Since 1983 he works in Switzerland\, first as a scientific member of t
 he Basel Institute for Immunology and since 2000 as the founding director 
 of the Institute for Research in Biomedicine in Bellinzona. Lanzavecchia h
 as been professor of Immunology at the University of Genova and Siena and 
 at the Swiss Federal Institute of technology\, ETH Zürich. He is member o
 f the EMBO\, fellow of the Royal College of Physicians and is honorary mem
 ber of the American Society for Immunology\, of the Swiss Society of Immun
 ology and of the Swiss Academy of Medical Sciences. In 2016 he has been el
 ected as international member of the U.S. National Academy of Sciences. He
  received the EMBO gold Medal\, the Cloetta prize\, the Robert Koch prize\
 , the Sanofi-Institut Pasteur prize and the Louis-Jeantet Prize for Medici
 ne. Lanzavecchia is the scientific Founder of Humabs Biomed\, now a subsid
 iary of Vir Biotecnology and is currently senior Research fellow at Vir Bi
 otecnology. His academic research continues at the INGM.\n\nSelected publi
 cations\n\nPhad\, G.E.\, Pinto\, D.\, Foglierini\, M. et al. Clonal struct
 ure\, stability and dynamics of human memory B cells and circulating plasm
 ablasts. Nat Immunol 23\, 1076–1085 (2022). https://doi.org/10.1038/s415
 90-022-01230-1 \n\nChen\, Y.\, Xu\, K.\, Piccoli\, L. et al. Structural b
 asis of malaria RIFIN binding by LILRB1-containing antibodies. Nature 592\
 , 639–643 (2021). https://doi.org/10.1038/s41586-021-03378-6\n\nCassotta
 \, A.\, Paparoditis\, P. et al. Deciphering and predicting CD4+ T cell imm
 unodominance of influenza virus hemagglutinin. J Exp Med 5 October 2020\; 
 217 (10): e20200206. doi: https://doi.org/10.1084/jem.20200206\n\n\nJoshua
  Tan\, Luca Piccoli\, Antonio Lanzavecchia. 2019. The Antibody Response to
  Plasmodium falciparum: Cues for Vaccine Design and the Discovery of Recep
 tor-Based Antibodies. Annual Review Immunology. 37:225-246. https://doi.or
 g/10.1146/annurev-immunol-042617-053301\n\n\n
ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/Anton
 io-thumbnail-1.png
CATEGORIES:Events in English,Tapahtumat
LOCATION:Osmo Järvi lecture hall\, Medisiina B/C\, Kiinamyllynkatu 10\, Tu
 rku\, Finland
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=Kiinamyllynkatu 10\, Turku\
 , Finland;X-APPLE-RADIUS=100;X-TITLE=Osmo Järvi lecture hall\, Medisiina 
 B/C:geo:0,0
END:VEVENT
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
X-LIC-LOCATION:Europe/Helsinki
BEGIN:DAYLIGHT
DTSTART:20260329T040000
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR